Showing results (1-10 of 252) with videos related to
Sort By:
Pageof 26
Expert Opinion on Pharmacotherapy|January 21, 2016
Overtreatment in cancer - is it a problem?Jaimin R Bhatt, Laurence KlotzNature Reviews. Urology|August 13, 2014
Landmarks in the diagnosis and treatment of renal cell carcinomaJaimin R Bhatt, Antonio FinelliTranslational Andrology and Urology|January 28, 2016
Active surveillance and focal therapy for low-intermediate risk prostate cancerLaurence KlotzWorld Journal of Urology|January 25, 2021
Overdiagnosis in urologic cancer : For World Journal of Urology Symposium on active surveillance in prostate and renal cancerLaurence KlotzCurrent Treatment Options in Oncology|August 15, 2006
Active surveillance versus radical treatment for favorable-risk localized prostate cancerLaurence KlotzEuropean Urology|December 8, 2004
Active surveillance with selective delayed intervention using PSA doubling time for good risk prostate cancerLaurence KlotzJournal of the National Comprehensive Cancer Network : JNCCN|August 19, 2007
Point: active surveillance for favorable risk prostate cancerLaurence KlotzUrologic Oncology|January 18, 2006
Active surveillance with selective delayed intervention for favorable risk prostate cancerLaurence KlotzClinical Prostate Cancer|March 26, 2004
Active surveillance with selective delayed intervention: a biologically nuanced approach to favorable-risk prostate cancerLaurence KlotzDrugs of Today (Barcelona, Spain : 1998)|January 14, 2010
Degarelix acetate for the treatment of prostate cancerLaurence KlotzPageof 26